AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal

Shares of Agile Therapeutics Inc. (AGRX) got pounded in extended trading on Tuesday despite positive results from SECURE, the company's phase III trial of its once-weekly contraceptive patch Twirla.

from RTT - Biotech http://ift.tt/2i8WcdF
via IFTTT